Potential Targets for Antifungal Agents

Summarise the clinical burden and epidemiology of invasive infections caused by Candida, Aspergillus and Cryptococcus, including drug-resistant species such as Candida auris, in terms suitable for the opening of a postgraduate report

Predict how an antifungal agent’s molecular mechanism will affect laboratory susceptibility findings, resistance detection, pathogen spectrum, toxicity and clinical use